Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Spinocerebellar Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT06681766
What this trial is testing

Assess Nomlabofusp in Adolescents and Children With Friedreich's Ataxia

Who this might be right for
Friedreich Ataxia
Larimar Therapeutics, Inc. 18
Very early researchStudy completedNCT02424435
What this trial is testing

Methylprednisolone Treatment of Friedreich Ataxia

Who this might be right for
Friedreich Ataxia
Children's Hospital of Philadelphia 11
Testing effectiveness (Phase 2)Study completedNCT07820579
What this trial is testing

Sirolimus Treatment in Pediatric Patients With Ataxia-Telangiectasia

Who this might be right for
Ataxia-Telangiectasia (A-T)Ataxia-Telangiectasia
Sara Elva Espinosa Padilla, MD 6
Not applicableWithdrawnNCT06560346
What this trial is testing

Understanding the Natural History Early in the Course or Presentation of Friedreich Ataxia

Who this might be right for
Friedreich AtaxiaRare Diseases
Friedreich's Ataxia Research Alliance
Not applicableLooking for participantsNCT02497534
What this trial is testing

Biomarkers in Friedreich's Ataxia

Who this might be right for
Friedreich's Ataxia
University of Florida 203
Large-scale testing (Phase 3)Study completedNCT00656409
What this trial is testing

Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT)

Who this might be right for
Ataxia Telangiectasia (AT)
Institute of Child Health 30
Large-scale testing (Phase 3)Study completedNCT06193200
What this trial is testing

Evaluate the Neurological Effects of EryDex on Subjects With A-T

Who this might be right for
Ataxia Telangiectasia
Quince Therapeutics S.p.A. 105
Early research (Phase 1)Study completedNCT04519567
What this trial is testing

Multiple Ascending Dose Study of CTI-1601 Versus Placebo in Subjects With Friedreich's Ataxia

Who this might be right for
Friedreich Ataxia
Larimar Therapeutics, Inc. 27
Not applicableWithdrawnNCT03770377
What this trial is testing

Laryngeal Adaptation for Speech and Swallowing

Who this might be right for
StrokeSpinocerebellar AtaxiaCerebral Stroke+2 more
University of Florida
Testing effectiveness (Phase 2)WithdrawnNCT03182894
What this trial is testing

Epacadostat in Combination With Pembrolizumab and Azacitidine in Subjects With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
James J Lee
Not applicableEnded earlyNCT02246491
What this trial is testing

Cell-Based Approaches For Modeling and Treating Ataxia-Telangiectasia

Who this might be right for
Ataxia-Telangiectasia (A-T)
Johns Hopkins University 6
Not applicableStudy completedNCT05028764
What this trial is testing

Determine Range of Tissue Frataxin Concentrations and Other Potential Biomarkers

Who this might be right for
Friedreich AtaxiaHealthy Volunteers
Larimar Therapeutics, Inc. 60
Early research (Phase 1)Looking for participantsNCT07180355
What this trial is testing

SGT-212 Gene Therapy in Friedreich's Ataxia

Who this might be right for
Friedreich's Ataxia (FA)
Solid Biosciences Inc. 10
Large-scale testing (Phase 3)Study completedNCT00697073
What this trial is testing

Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients

Who this might be right for
Friedreich's Ataxia
Santhera Pharmaceuticals 68
Testing effectiveness (Phase 2)Study completedNCT00034242
What this trial is testing

High-Dose Intravenous Immunoglobulin to Treat Cerebellar Degeneration

Who this might be right for
Spinocerebellar Degenerations
National Institute of Neurological Disorders and Stroke (NINDS) 20
Testing effectiveness (Phase 2)Looking for participantsNCT07506109
What this trial is testing

A Phase II Study of Sintilimab Combined With Ipilimumab N01, Cetuximab and Dabrafenib in Patients With Microsatellite-Stable, BRAF V600E-Mutated Metastatic Colorectal Cancer

Who this might be right for
BRAF V600EColorectal CancerSintilimab+4 more
Tianjin Medical University Cancer Institute and Hospital 49
Not applicableStudy completedNCT00187057
What this trial is testing

Study for Treatment of Cancer in Children With Ataxia-telangiectasia

Who this might be right for
Ataxia-Telangiectasia
St. Jude Children's Research Hospital 6
Large-scale testing (Phase 3)Study completedNCT01970111
What this trial is testing

An Extension Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Who this might be right for
Spinocerebellar Degeneration
Kissei Pharmaceutical Co., Ltd.
Not applicableStudy completedNCT00136630
What this trial is testing

Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations

Who this might be right for
Spinocerebellar AtaxiasSpastic Paraplegias
Institut National de la Santé Et de la Recherche Médicale, France 175
Large-scale testing (Phase 3)Ended earlyNCT06664853
What this trial is testing

Open-Label Extension of EryDex Study IEDAT-04-2022

Who this might be right for
Ataxia Telangiectasia
Quince Therapeutics S.p.A. 101
Next Page